Humacyte Inc
NASDAQ:HUMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Humacyte Inc
NASDAQ:HUMA
|
US |
|
Lite-On Technology Corp
TWSE:2301
|
TW |
|
Far Eastern New Century Corp
TWSE:1402
|
TW |
|
S
|
Stalprodukt SA
WSE:STP
|
PL |
|
Montagne et Neige Developpement SA
PAR:ALMND
|
FR |
|
O
|
Ocean Glass PCL
SET:OGC
|
TH |
|
Great Elm Group Inc
F:PNC
|
US |
|
Tokai Corp (Gifu)
TSE:9729
|
JP |
|
R
|
River Tech plc
OSE:RIVER
|
MT |
|
S
|
Sepatu Bata Tbk PT
IDX:BATA
|
ID |
|
Mondo TV SpA
MIL:MTV
|
IT |
|
A
|
Artifex Mundi SA
WSE:ART
|
PL |
|
Bufab AB (publ)
STO:BUFAB
|
SE |
|
Palantir Technologies Inc
NASDAQ:PLTR
|
US |
|
S
|
Sherwood Corporation (Thailand) PCL
SET:SWC
|
TH |
|
System1 Group PLC
LSE:SYS1
|
UK |
|
A
|
Akar Auto Industries Ltd
BSE:530621
|
IN |
|
WildBrain Ltd
TSX:WILD
|
CA |
|
U
|
Unitronix Corp
OTC:UTRX
|
US |
|
Prim SA
MAD:PRM
|
ES |
|
R
|
Radian Group Inc
XBER:RAG
|
US |
|
V
|
Vast Resources PLC
XBER:D9A
|
UK |
|
Hudson Investment Group Ltd
ASX:HGL
|
AU |
|
Carparts.Com Inc
NASDAQ:PRTS
|
US |
Bankruptcy Probability
Humacyte Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Humacyte Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Humacyte Inc
NASDAQ:HUMA
|
192.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
456.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
236.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Humacyte Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Humacyte Inc has total debt of 64.7m USD. This includes both short-term (0 USD) and long-term (64.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
